Axis Announces Integration of OMNIMED SmartOR in Nashville, Chattanooga, Irvine & Columbia

Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and testing, announced the integration of OMNIMED™ SmartOR™ across its four locations (Nashville, Tenn., Chattanooga, Tenn. Irvine, Calif., Columbia, Md.).  OMNIMED SmartOR is a customized network of modular, data-driven technologies that sense, observe, and understand the complex activities of laboratory surgical suites and hospital operating rooms.

“The integration of OMNIMED SmartOR into Axis’s distinguished bioskills lab facilities across the U.S. dramatically changes the playing field for medical device testing,” said Hugh Dodson, CFO and COO of OMNIMED. “For the first time ever, medical device companies, surgeons and researchers can access real-time data from intraoperative procedures to make educated, informed decisions that will improve performance and guide best practices.”

OMNIMED SmartOR’s SaaS model and technology platform uses a combination of secure, sophisticated technologies to gain access to millions of data points and real-time information. These insights inform decision-making and improve efficiencies, accuracies, and procedures. Data is highly encrypted in transit and protected to prevent theft and loss.

“Introducing OMNIMED SmartOR into Axis facilities will enhance research and development, marketing exposure, and sales implementation for medical device companies, and provide more robust training for all healthcare providers,” said Dr. Mark G. Freeman, a board-certified orthopedic surgeon from Chattanooga, Tenn. and Chief Medical Advisor at Axis Research & Technologies. “More importantly, the adoption of this disruptive, innovative technology into hospitals, surgery centers and educational lab settings will reduce costs, increase efficiencies in care, improve patient outcomes, and deliver better value-based healthcare.”

OMNIMED SmartOR was created in collaboration with leading names in the healthcare industry including Johns Hopkins Applied Physics Laboratory, Maya HTT, BDO’s Center for Healthcare Excellence and Innovation and BDO Digital, and Axis Research & Technologies.

“OMNIMED SmartOR is the future of operating rooms, surgical centers, and other procedure-based facilities,” continued Dr. Freeman.

Axis’s high-tech educational lab settings and event facilities are staffed with well-trained, highly organized, and knowledgeable personnel who provide unmatched levels of service. Clients are free to focus on their medical education, symposium, or surgical training while the professionals at Axis oversee every detail to make each event a success. Available services include tissue sourcing, specimen preparation, equipment readiness, and room configuration. Catering and other customizable on-site offerings are available upon request.

“Data is rapidly changing how laboratories operate,” said Jill Goodwin, COO of Axis Research & Technologies. “Our partnership with OMNIMED is a game-changer for our clients who come from around the globe to conduct research and development as well as didactic and cadaver training.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version